199 related articles for article (PubMed ID: 32147272)
21. Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology.
Gopalan V; Smith RA; Ho YH; Lam AK
Int J Colorectal Dis; 2011 Feb; 26(2):127-33. PubMed ID: 20686774
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
[TBL] [Abstract][Full Text] [Related]
23. Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene.
Sugimoto S; Yamada H; Takahashi M; Morohoshi Y; Yamaguchi N; Tsunoda Y; Hayashi H; Sugimura H; Komatsu H
Gastric Cancer; 2014 Oct; 17(4):745-9. PubMed ID: 23812922
[TBL] [Abstract][Full Text] [Related]
24. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
25. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature.
Hamilton LE; Jones K; Church N; Medlicott S
BMC Gastroenterol; 2013 Jul; 13():114. PubMed ID: 23849133
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
27. Distinct expression patterns of E-cadherin and beta-catenin in signet ring cell carcinoma components of primary pulmonary adenocarcinoma.
Moon KC; Cho SY; Lee HS; Jeon YK; Chung JH; Jung KC; Chung DH
Arch Pathol Lab Med; 2006 Sep; 130(9):1320-5. PubMed ID: 16948518
[TBL] [Abstract][Full Text] [Related]
28. Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
Korphaisarn K; Morris V; Davis JS; Overman MJ; Fogelman DR; Kee BK; Dasari A; Raghav KPS; Shureiqi I; Trupti M; Wolff RA; Eng C; Menter DG; Hamilton S; Kopetz S
Br J Cancer; 2019 Sep; 121(6):505-510. PubMed ID: 31406299
[TBL] [Abstract][Full Text] [Related]
29. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
30. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers.
van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A
Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363
[TBL] [Abstract][Full Text] [Related]
31. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
[TBL] [Abstract][Full Text] [Related]
32. Reduced E-cadherin expression as a cause of distinctive signet-ring cell variant in colorectal carcinoma.
Kim HC; Kim HJ; Kim JC
J Korean Med Sci; 2002 Feb; 17(1):23-8. PubMed ID: 11850584
[TBL] [Abstract][Full Text] [Related]
33. Novel mechanism of a CDH1 splicing mutation in a Korean patient with signet ring cell carcinoma.
Kim S; Ki CS; Kim KM; Lee MG; Kim S; Bae JM; Kim JW
BMB Rep; 2011 Nov; 44(11):725-9. PubMed ID: 22118538
[TBL] [Abstract][Full Text] [Related]
34. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
35. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity.
Humar B; Guilford P
Cancer Sci; 2009 Jul; 100(7):1151-7. PubMed ID: 19432899
[TBL] [Abstract][Full Text] [Related]
36. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.
Oliveira C; de Bruin J; Nabais S; Ligtenberg M; Moutinho C; Nagengast FM; Seruca R; van Krieken H; Carneiro F
Oncogene; 2004 Mar; 23(12):2236-40. PubMed ID: 14661064
[TBL] [Abstract][Full Text] [Related]
37. The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma.
Wang R; Ma X; Li Y; He Y; Huang D; Cai S; Peng J
PLoS One; 2016; 11(8):e0160527. PubMed ID: 27509205
[TBL] [Abstract][Full Text] [Related]
38. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis.
Hartman DJ; Nikiforova MN; Chang DT; Chu E; Bahary N; Brand RE; Zureikat AH; Zeh HJ; Choudry H; Pai RK
Am J Surg Pathol; 2013 Jul; 37(7):969-77. PubMed ID: 23681075
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin gene mutations in signet ring cell carcinoma of the stomach.
Muta H; Noguchi M; Kanai Y; Ochiai A; Nawata H; Hirohashi S
Jpn J Cancer Res; 1996 Aug; 87(8):843-8. PubMed ID: 8797891
[TBL] [Abstract][Full Text] [Related]
40. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
